Manufacturing GMP-Compliant iPSCs In Closed And Open Systems

Understand what it takes to transition human induced pluripotent stem cell (iPSC) production from research to clinically relevant manufacturing. Insights from Dr. Dhruv Sareen highlight the critical considerations for establishing robust, reproducible iPSC processes under current Good Manufacturing Practices (cGMP), including quality control, scalability, and regulatory alignment. Complementing this perspective, Dr. Chao Sheng introduces an integrated workflow designed to support GMP-compliant expansion of human pluripotent stem cells, with a focus on automation and consistency through advanced adherent culture technology. Together, these perspectives offer a practical view into building reliable cell manufacturing pipelines.

Watch the full webinar to explore strategies for advancing cell therapy workflows.